Intercept Pharmaceuticals Announces First Quarter 2015 Financial Results – Nasdaq

Intercept Pharmaceuticals Announces First Quarter 2015 Financial Results
Nasdaq
On April 10, 2014, all warrants outstanding as of March 31, 2014 were exercised on a cashless basis and converted into shares of Intercept common stock. As such, the Company recorded a final adjustment of approximately $56 million in non-cash income in …

and more

…read more

Scroll to Top